Functional activity of ex-vivo produced ProT-NK cells.
Feeder-cell-free system for ex vivo production of natural killer cells from cord blood hematopoietic stem and progenitor cells
This study presents a feeder-cell-free two-step culture system for ex vivo generation of natural killer (NK) cells from cord blood CD34+ hematopoietic stem and progenitor cells (HSPCs). Cells are first differentiated into T-lymphoid progenitors, then into highly pure CD3−CD56+ NK cells within 14–21 days. Generated ProT-NK cells display immature phenotype but express key activating receptors and cytotoxic molecules, show degranulation and TNF-α production upon K562 stimulation, and demonstrate superior cytotoxicity in vitro. In NSG-hIL15 mice, they home to bone marrow, liver, and spleen, persist at least 9 days, and show anti-tumor activity, offering a scalable alternative to PB-NK therapies.
Key Findings
An optimized feeder-cell-free two-step culture was established to generate NK cells from cord blood CD34+ HSPCs, yielding >90% pure CD3−CD56+ ProT-NK cells within 14 days in scalable formats. These cells exhibit an immature phenotype (CD16−, KIR−, EOMES low) but express activating receptors (NKp30, NKp44, NKp46, DNAM-1, NKG2D), transcription factors ID2 and T-bet, and cytotoxic molecules perforin and granzyme B. ProT-NK D14 cells efficiently degranulated and produced TNF-α in response to K562 cells, with cytotoxicity superior to peripheral blood NK cells. In NSG-Tg(hIL-15) mice, ProT-NK cells colonized bone marrow, liver, and spleen, persisted for at least 9 days, and could mature in vivo. Using a subcutaneous K562 xenograft model, ProT-NK D14 cells demonstrated anti-tumor activity and improved survival. Lentiviral transduction further enabled generation of CAR-ProT-NK cells, supporting their potential for off-the-shelf NK cell immunotherapy.
Contribution
Creative Biogene provided the K562-GFP/Luc cell line (CSC-RR0374) used to establish the tumor model for evaluating ProT-NK anti-tumor activity in vivo.
Figure 1. Researchers transfected K562 cells with luciferase reporter plasmid under HRE promoter to assess RUNX1 and ASXL1 mutant effects. They incubated cells with CoCl2 to mimic hypoxic conditions and evaluated luciferase activities. Relative luciferase intensity normalized to GFP and EV control was measured after 72 hours. (Bera R, et al., 2019)